139 related articles for article (PubMed ID: 15801953)
1. Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial.
Roy A; Bradburn M; Moorman AV; Burrett J; Love S; Kinsey SE; Mitchell C; Vora A; Eden T; Lilleyman JS; Hann I; Saha V;
Br J Haematol; 2005 Apr; 129(1):35-44. PubMed ID: 15801953
[TBL] [Abstract][Full Text] [Related]
2. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
Hann I; Vora A; Richards S; Hill F; Gibson B; Lilleyman J; Kinsey S; Mitchell C; Eden OB
Leukemia; 2000 Mar; 14(3):356-63. PubMed ID: 10720126
[TBL] [Abstract][Full Text] [Related]
3. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
Hann I; Vora A; Harrison G; Harrison C; Eden O; Hill F; Gibson B; Richards S;
Br J Haematol; 2001 Apr; 113(1):103-14. PubMed ID: 11328289
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI.
Wheeler KA; Richards SM; Bailey CC; Gibson B; Hann IM; Hill FG; Chessells JM
Blood; 2000 Oct; 96(7):2412-8. PubMed ID: 11001892
[TBL] [Abstract][Full Text] [Related]
5. Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome.
Schrappe M; Aricò M; Harbott J; Biondi A; Zimmermann M; Conter V; Reiter A; Valsecchi MG; Gadner H; Basso G; Bartram CR; Lampert F; Riehm H; Masera G
Blood; 1998 Oct; 92(8):2730-41. PubMed ID: 9763557
[TBL] [Abstract][Full Text] [Related]
6. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
Eden OB; Lilleyman JS; Richards S; Shaw MP; Peto J
Br J Haematol; 1991 Jun; 78(2):187-96. PubMed ID: 2064956
[TBL] [Abstract][Full Text] [Related]
7. The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.
Lawson SE; Harrison G; Richards S; Oakhill A; Stevens R; Eden OB; Darbyshire PJ
Br J Haematol; 2000 Mar; 108(3):531-43. PubMed ID: 10759711
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X.
Chessells JM; Bailey C; Wheeler K; Richards SM
Lancet; 1992 Sep; 340(8819):565-8. PubMed ID: 1355153
[TBL] [Abstract][Full Text] [Related]
9. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
Chessells JM; Bailey C; Richards SM
Lancet; 1995 Jan; 345(8943):143-8. PubMed ID: 7823668
[TBL] [Abstract][Full Text] [Related]
10. Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.
Ramanujachar R; Richards S; Hann I; Goldstone A; Mitchell C; Vora A; Rowe J; Webb D
Pediatr Blood Cancer; 2007 Mar; 48(3):254-61. PubMed ID: 16421910
[TBL] [Abstract][Full Text] [Related]
11. Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia.
Richards S; Burrett J; Hann I; Chessells J; Hill F; Bailey C
Leukemia; 1998 Jul; 12(7):1031-6. PubMed ID: 9665186
[TBL] [Abstract][Full Text] [Related]
12. The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99.
Mitchell C; Payne J; Wade R; Vora A; Kinsey S; Richards S; Eden T
Br J Haematol; 2009 Aug; 146(4):424-36. PubMed ID: 19549269
[TBL] [Abstract][Full Text] [Related]
13. Outcome of patients with acute lymphoblastic leukemia (ALL) following induction therapy with a modified (pulsed dexamethasone rather than continuous prednisone) UKALL XII/ECOG E2993 protocol at Tawam Hospital, United Arab Emirates (UAE).
Hassan IB; Kristensen J; Alizadeh H; Bernsen R
Med Oncol; 2013 Jun; 30(2):519. PubMed ID: 23468219
[TBL] [Abstract][Full Text] [Related]
14. Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia.
Wheeler K; Richards S; Bailey C; Chessells J
Br J Haematol; 1998 Apr; 101(1):94-103. PubMed ID: 9576189
[TBL] [Abstract][Full Text] [Related]
15. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
16. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
17. Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI.
Chessells JM; Harrison G; Richards SM; Gibson BE; Bailey CC; Hill FG; Hann IM;
Br J Haematol; 2002 Aug; 118(2):445-55. PubMed ID: 12139731
[TBL] [Abstract][Full Text] [Related]
18. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
Hongo T; Yajima S; Sakurai M; Horikoshi Y; Hanada R
Blood; 1997 Apr; 89(8):2959-65. PubMed ID: 9108416
[TBL] [Abstract][Full Text] [Related]
19. Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study.
Biondi A; Schrappe M; De Lorenzo P; Castor A; Lucchini G; Gandemer V; Pieters R; Stary J; Escherich G; Campbell M; Li CK; Vora A; Aricò M; Röttgers S; Saha V; Valsecchi MG
Lancet Oncol; 2012 Sep; 13(9):936-45. PubMed ID: 22898679
[TBL] [Abstract][Full Text] [Related]
20. The Medical Research Council trials in adult acute lymphocytic leukemia.
Durrant IJ; Richards SM; Prentice HG; Goldstone AH
Hematol Oncol Clin North Am; 2000 Dec; 14(6):1327-52. PubMed ID: 11147226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
